Hollingsworth, S., Johnson, S., Khakbaz, P., Meng, Y., Mouchlis, V., Pierce, O., . . . Shanmugasundaram, V. (2023). The rise of targeting chimeras (TACs): Next-generation medicines that preempt cellular events. Medicinal Chemistry Research, 32(7), 1294. https://doi.org/10.1007/s00044-023-03104-z
Chicago Style (17th ed.) CitationHollingsworth, Scott, et al. "The Rise of Targeting Chimeras (TACs): Next-generation Medicines That Preempt Cellular Events." Medicinal Chemistry Research 32, no. 7 (2023): 1294. https://doi.org/10.1007/s00044-023-03104-z.
MLA (9th ed.) CitationHollingsworth, Scott, et al. "The Rise of Targeting Chimeras (TACs): Next-generation Medicines That Preempt Cellular Events." Medicinal Chemistry Research, vol. 32, no. 7, 2023, p. 1294, https://doi.org/10.1007/s00044-023-03104-z.